OncoMed Pharmaceuticals, Inc. EBITDA 2013-2018 | OMED
OncoMed Pharmaceuticals, Inc. ebitda from 2013 to 2018. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| OncoMed Pharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2018 | $-8 |
| 2017 | $-39 |
| 2016 | $-102 |
| 2015 | $-84 |
| 2014 | $-49 |
| 2013 | $-23 |
| 2012 | $-21 |
| 2011 | $-14 |
| 2010 | $-26 |
| OncoMed Pharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2018-12-31 | $-5 |
| 2018-09-30 | $6 |
| 2018-06-30 | $-4 |
| 2018-03-31 | $-6 |
| 2017-12-31 | $9 |
| 2017-09-30 | $-11 |
| 2017-06-30 | $-15 |
| 2017-03-31 | $-22 |
| 2016-12-31 | $-22 |
| 2016-09-30 | $-25 |
| 2016-06-30 | $-27 |
| 2016-03-31 | $-27 |
| 2015-12-31 | $-24 |
| 2015-09-30 | $-24 |
| 2015-06-30 | $-21 |
| 2015-03-31 | $-14 |
| 2014-12-31 | $-15 |
| 2014-09-30 | $-5 |
| 2014-06-30 | $-15 |
| 2014-03-31 | $-14 |
| 2013-12-31 | $-2 |
| 2013-09-30 | $-3 |
| 2013-06-30 | $-9 |
| 2013-03-31 | $-8 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-4 |
